Learn, Analyse & Invest
only with

+91

Download Orca

To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Themis Medicare Ltd.

Themis Medicare

₹ 0.00

0.00 (0.00)%

NSE

BSE

Healthcare

Small-cap - With a market cap of ₹9.23 Cr.

EX-Date	Purpose
27 05 2021	Final Dividend & Audited Results
13 08 2021	Quarterly Results
12 11 2021	Quarterly Results
11 02 2022	Quarterly Results
21 05 2022	Final Dividend & Audited Results
28 07 2022	Quarterly Results
07 11 2022	Quarterly Results
03 02 2023	Quarterly Results
13 05 2023	Stock Split & Final Dividend & Audited Results
10 08 2023	Quarterly Results (Revised)
12 08 2023	Quarterly Results
04 11 2023	Quarterly Results
10 02 2024	Quarterly Results
25 10 2024	Quarterly Results
14 02 2025	Quarterly Results
20 05 2025	Final Dividend & Audited Results

News

04-JAN-2023

Lenzetto is manufactured in Europe by Gedeon Richter, The Global Innovators in Women’s Health

09:35 AM

07-OCT-2022

Once the study is approved, the clinical trial will be conducted in India, targeting 334 smokers

10:50 AM

08-NOV-2022

Cash consideration amounting to Rs 125 crore will be payable by the transferee company to the transferor company

10:44 AM

10-NOV-2023

The company has done pioneering work by conducting phase III trials at 13 centers in India before getting Remifentanil approved by the regulators

03:42 PM

17-FEB-2023

Themis will market this drug with the brand name Remithem

02:58 PM

20-SEP-2023

The company has incorporated wholly owned subsidiary of the Company in the name of ‘Rx Themis’ on September 19, 2023

02:22 PM